Tema Oncology ETF Rating $25.84 -0.06 (-0.21%) As of 02/21/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Tema Oncology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CANC Aggregate RatingModerate Buy 2.80Holdings in CANC have an aggregate rating of Moderate Buy based on 600 analyst ratings issued in the past year covering 43 companies (79.0% of the portfolio).CANC Aggregate Price Target$25.86High Prediction$25.86Average Prediction$25.86Low Prediction$25.86Holdings in CANC have an aggregate price target of $25.86 and a range of $25.86 to $25.86 covering 43 companies (79.0% of the portfolio).CANC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Oncology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 43 CANC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.48%LLYEli Lilly and Company$874.12+0.1%4.8538 of 5 stars2.85$1,007.94 15.3%20Positive News4.33%BBIOBridgeBio Pharma$36.85+0.1%4.8297 of 5 stars2.92$51.67 40.2%13Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap Up4.09%RVMDRevolution Medicines$41.34-2.2%4.5213 of 5 stars3.08$66.25 60.3%124.03%MRKMerck & Co., Inc.$89.40+2.0%5 of 5 stars2.58$116.39 30.2%24Analyst DowngradeOptions Volume3.94%RHHBYRoche$41.42+0.7%N/A2.4373.83%BMYBristol-Myers Squibb$55.85+0.1%4.5959 of 5 stars2.30$57.86 3.6%20Analyst RevisionPositive News3.75%GMABGenmab A/S$22.34-0.4%4.5963 of 5 stars2.75$42.17 88.7%123.68%EXELExelixis$36.85+5.0%4.5093 of 5 stars2.55$37.24 1.0%20Analyst UpgradeInsider Trade3.20%AMGNAmgen$303.01+1.7%4.4751 of 5 stars2.46$314.09 3.7%24Insider TradePositive News3.19%NUVLNuvalent$79.49-3.5%2.1161 of 5 stars2.86$112.36 41.4%14Upcoming EarningsInsider Trade2.87%SMMTSummit Therapeutics$22.12-4.1%2.3077 of 5 stars2.86$33.57 51.8%72.82%LEGNLegend Biotech$39.70+2.0%2.5296 of 5 stars3.00$79.50 100.3%12News CoveragePositive News2.20%GILDGilead Sciences$109.95-0.1%4.7947 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News2.15%ABBVAbbVie$202.03+0.6%4.6572 of 5 stars2.88$208.35 3.1%24Dividend AnnouncementAnalyst RevisionPositive News1.98%ARGXargenx$644.48-0.5%2.5007 of 5 stars2.86$658.39 2.2%22News CoveragePositive News1.96%MRUSMerus$47.37-0.5%2.9171 of 5 stars3.13$85.92 81.4%161.76%DAWNDay One Biopharmaceuticals$12.43+1.6%2.1039 of 5 stars3.00$35.71 187.3%9Upcoming EarningsInsider TradeNews Coverage1.55%ACLXArcellx$63.75-2.8%2.0095 of 5 stars3.13$105.93 66.2%15Upcoming Earnings1.48%JANXJanux Therapeutics$36.01-3.1%3.1354 of 5 stars3.08$89.90 149.7%131.47%IDYAIDEAYA Biosciences$21.75+0.1%3.8315 of 5 stars2.93$53.58 146.4%15Gap Up1.46%BPMCBlueprint Medicines$92.25-2.2%2.9944 of 5 stars2.65$123.83 34.2%20Earnings ReportAnalyst Upgrade1.13%SWTXSpringWorks Therapeutics$58.29-2.7%1.2401 of 5 stars3.00$71.50 22.7%6Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.13%MREOMereo BioPharma Group$2.86-0.5%3.0514 of 5 stars3.43$7.83 174.4%7News Coverage1.10%GHGuardant Health$42.87-9.6%4.2489 of 5 stars3.00$44.78 4.5%18Earnings ReportAnalyst ForecastNews CoverageGap UpHigh Trading Volume1.10%REGNRegeneron Pharmaceuticals$700.33+0.6%4.6674 of 5 stars2.76$973.13 39.0%25Dividend Announcement1.06%INCYIncyte$72.05+0.9%4.541 of 5 stars2.35$75.59 4.9%201.05%LNTHLantheus$78.23-3.2%4.5852 of 5 stars3.00$131.86 68.6%7Analyst RevisionNews CoveragePositive News0.96%ARVNArvinas$17.77-3.3%3.0951 of 5 stars3.00$60.00 237.6%12Gap Up0.96%CGONCG Oncology$27.85-1.3%1.8313 of 5 stars3.11$65.14 133.9%9News CoveragePositive News0.93%SDGRSchrödinger$22.64-5.7%1.793 of 5 stars2.80$32.11 41.8%10Upcoming Earnings0.90%EXASExact Sciences$49.26-0.5%4.6972 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.87%COGTCogent Biosciences$8.00-1.1%1.5442 of 5 stars2.50$14.33 79.2%60.81%NRIXNurix Therapeutics$16.87-1.0%1.5522 of 5 stars2.94$31.81 88.6%160.78%ILMNIllumina$94.20-3.1%4.7855 of 5 stars2.62$159.45 69.3%210.77%AGIOAgios Pharmaceuticals$35.22+4.3%4.3488 of 5 stars2.50$56.33 60.0%8Earnings ReportShort Interest ↓0.72%ZYMEZymeworks$14.39+2.6%2.0962 of 5 stars2.86$19.17 33.2%70.68%IMCRImmunocore$29.92+0.2%1.4211 of 5 stars2.54$65.64 119.4%130.58%RCUSArcus Biosciences$11.06+3.0%2.6026 of 5 stars2.90$29.50 166.7%10Analyst ForecastAnalyst RevisionNews Coverage0.56%CGEMCullinan Therapeutics$9.03-1.3%2.3347 of 5 stars3.00$32.50 259.9%70.53%RLAYRelay Therapeutics$3.92-4.2%1.6323 of 5 stars2.90$20.50 423.0%10Positive News0.50%ORICORIC Pharmaceuticals$7.68+2.8%4.5474 of 5 stars3.00$18.71 143.7%9Earnings ReportAnalyst ForecastAnalyst RevisionGap Up0.32%AUTLAutolus Therapeutics$1.952.9227 of 5 stars3.00$10.40 433.3%5Gap Up0.29%CELCCelcuity$13.15+0.2%1.761 of 5 stars3.14$30.17 129.4%7 This page (NASDAQ:CANC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANC Stock Alerts